Literature DB >> 15380631

Drug release from injectable depots: two different in vitro mechanisms.

Liwei Wang1, Subbu Venkatraman, Lothar Kleiner.   

Abstract

Certain poly (lactide-co-glycolide) (PLGA)/benzyl benzoate (BB) solutions can form gels when injected into buffer (depot formation) as well as upon ageing under ambient conditions. When evaluating various PLGAs in benzyl benzoate, we have found that only those that gel upon ageing also form gel depots in buffer. This indicates that depot formation in this system may be fundamentally different from the phase inversion depot formation that has been observed for PLGA in water-miscible solvents. The drug release kinetics in vitro is controlled both by diffusion and erosion, with the base form of the drug being always released faster than its salt form. This is due to base-catalyzed hydrolysis. While gel permeation chromatography (GPC) measurements show a continuous decrease in molecular weight, the rheological properties upon buffer injection show maxima, for the base drug and the salt drug. The location of the viscosity maximum with time is dependent on the nature of the drug and its concentration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380631     DOI: 10.1016/j.jconrel.2004.06.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  In vitro-controlled release delivery system for hydrogen sulfide donor.

Authors:  Hatim Ali; Catherine Opere; Somnath Singh
Journal:  AAPS PharmSciTech       Date:  2014-04-24       Impact factor: 3.246

2.  The Effect of Additives on the Behavior of Phase Sensitive In Situ Forming Implants.

Authors:  Luis Solorio; Divya Sundarapandiyan; Alex Olear; Agata A Exner
Journal:  J Pharm Sci       Date:  2015-07-14       Impact factor: 3.534

3.  Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release.

Authors:  Veronika Schmitt; Claudia Kesch; John K Jackson; Samir Bidnur; Eliana Beraldi; Virginia Yago; Mary Bowden; Martin E Gleave
Journal:  Pharm Res       Date:  2020-01-21       Impact factor: 4.200

Review 4.  Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.

Authors:  Jie Shen; Diane J Burgess
Journal:  J Pharm Pharmacol       Date:  2012-03-08       Impact factor: 3.765

Review 5.  Long-acting injectable PLGA/PLA depots for leuprolide acetate: successful translation from bench to clinic.

Authors:  Samer R Abulateefeh
Journal:  Drug Deliv Transl Res       Date:  2022-08-17       Impact factor: 5.671

6.  Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.

Authors:  Heba A Gad; Mohamed A El-Nabarawi; Seham S Abd El-Hady
Journal:  AAPS PharmSciTech       Date:  2008-07-25       Impact factor: 3.246

7.  Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots.

Authors:  Karin Schoenhammer; Holger Petersen; Frank Guethlein; Achim Goepferich
Journal:  Pharm Res       Date:  2009-10-01       Impact factor: 4.200

8.  Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.

Authors:  Tarek A Ahmed; Hany M Ibrahim; Ahmed M Samy; Alaa Kaseem; Mohammad T H Nutan; Muhammad Delwar Hussain
Journal:  AAPS PharmSciTech       Date:  2014-03-20       Impact factor: 3.246

9.  A biodegradable ocular implant for long-term suppression of intraocular pressure.

Authors:  Xu Wen Ng; Kerh Lin Liu; Amutha Barathi Veluchamy; Nyein Chan Lwin; Tina T Wong; Subbu S Venkatraman
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

10.  Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation.

Authors:  Tarek A Ahmed; Yasser A Alharby; Abdel-Rahim M El-Helw; Khaled M Hosny; Khalid M El-Say
Journal:  Drug Des Devel Ther       Date:  2016-01-20       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.